Search Medical Condition
Please enter condition
Please choose location

Diabetes (Pediatric) Clinical Trials

A listing of Diabetes (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (32) clinical trials

Winthrop University Hospital Clinical Trials Center is conducting a clinical research study for participants (ages 10-17 years old), who have been diagnosed with type 2 diabetes. The purpose of this research study is to test the safety and effectiveness of an oral investigational drug to lower blood sugar in Pediatric ...

Phase

A study to evaluate the two new sensors performance in pediatric patients with insulin requiring diabetes

Phase N/A

To confirm the effect of treatment with meal-time faster-acting insulin aspart in terms of glycaemic control by comparing it to meal-time NovoRapid®, both in combination with insulin degludec using a non-inferiority approach in children and adolescents with type 1 diabetes.

Phase N/A

The purpose of this research study is to investigate whether the trial product is effective and safe in reducing/managing weight in children. Winthrop-University Hospital Clinical Trials Center is seeking study participants (ages 7-11 years old), who have not started puberty to take part in this clinical research study because he/she ...

Phase

A research study is evaluating the combination of two FDA-approved medications for Pediatric Type 2 Diabetes. This research study may be an option if your child:  Has a diagnosis of Type 2 Diabetes  Has an HbA1C of 6.5% - 10%  Has a parent/guardian that is closely involved in the daily ...

Phase N/A

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

The patients are expected to participate in the study for approximately 6 to 8 weeks from Screening to final follow-up visit. Patients who completed 4 weeks of Afrezza treatment and have shown to be safe and well controlled with Afrezza + basal insulin will have the option to continue the ...

Phase

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

The study will proceed as follows: Run-in Period - General: A total of up to 200 subjects (age 2-13) will be enrolled at up to 15 investigational centers (14 in the US, 1 EMEA) in order to reach 120 subjects who will complete the HCL study. Study Period - At ...

Phase N/A

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home

This is a 6 month, multi-center, randomized, parallel, adaptive study in type 1 diabetes with a 6 month continuation period. The study will have three periods: Run-in Period: The run-in period can be up to 60 days during which time a blinded CGM sensor will be worn for two weeks. ...

Phase N/A